Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study.
Mizuno Y, Bies RR, Remington G, Mamo DC, Suzuki T, Pollock BG, Tsuboi T, Watanabe K, Mimura M, Uchida H. Mizuno Y, et al. Among authors: tsuboi t. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):182-7. doi: 10.1016/j.pnpbp.2011.12.013. Epub 2011 Dec 30. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22230651 Clinical Trial.
Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey.
Tani H, Uchida H, Suzuki T, Shibuya Y, Shimanuki H, Watanabe K, Den R, Nishimoto M, Hirano J, Takeuchi H, Nio S, Nakajima S, Kitahata R, Tsuboi T, Tsunoda K, Kikuchi T, Mimura M. Tani H, et al. Among authors: tsuboi t. BMC Oral Health. 2012 Aug 18;12:32. doi: 10.1186/1472-6831-12-32. BMC Oral Health. 2012. PMID: 22901247 Free PMC article.
A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
Ikai S, Remington G, Suzuki T, Takeuchi H, Tsuboi T, Den R, Hirano J, Tsunoda K, Nishimoto M, Watanabe K, Mimura M, Mamo D, Uchida H. Ikai S, et al. Among authors: tsuboi t. J Clin Psychiatry. 2012 Aug;73(8):1147-52. doi: 10.4088/JCP.12m07638. J Clin Psychiatry. 2012. PMID: 22967779
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).
Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K. Tsuboi T, et al. Neuropsychiatr Dis Treat. 2020 Mar 31;16:881-890. doi: 10.2147/NDT.S246136. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32280229 Free PMC article.
Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).
Kato M, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Tsuboi T, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Kinoshita T, Watanabe Y, Miki K, Watanabe K. Kato M, et al. Among authors: tsuboi t. J Psychiatr Res. 2020 Dec;131:228-234. doi: 10.1016/j.jpsychires.2020.09.030. Epub 2020 Sep 30. J Psychiatr Res. 2020. PMID: 33022523
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study.
Adachi N, Azekawa T, Edagawa K, Goto E, Hongo S, Kato M, Katsumoto E, Kikuchi T, Kubota Y, Miki K, Nakagawa A, Tsuboi T, Ueda H, Watanabe K, Watanabe Y, Yasui-Furukori N, Yoshimura R. Adachi N, et al. Among authors: tsuboi t. Hum Psychopharmacol. 2021 Mar;36(2):e2764. doi: 10.1002/hup.2764. Epub 2020 Oct 22. Hum Psychopharmacol. 2021. PMID: 33089907
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder.
Yasui-Furukori N, Adachi N, Kubota Y, Azekawa T, Goto E, Edagawa K, Katsumoto E, Hongo S, Ueda H, Miki K, Kato M, Yoshimura R, Nakagawa A, Kikuchi T, Tsuboi T, Watanabe K, Shimoda K. Yasui-Furukori N, et al. Among authors: tsuboi t. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):599-606. doi: 10.9758/cpn.2020.18.4.599. Clin Psychopharmacol Neurosci. 2020. PMID: 33124592 Free PMC article.
Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder.
Tokumitsu K, Yasui-Furukori N, Adachi N, Kubota Y, Watanabe Y, Miki K, Azekawa T, Edagawa K, Katsumoto E, Hongo S, Goto E, Ueda H, Kato M, Yoshimura R, Nakagawa A, Kikuchi T, Tsuboi T, Shimoda K, Watanabe K. Tokumitsu K, et al. Among authors: tsuboi t. BMC Psychiatry. 2020 Nov 23;20(1):555. doi: 10.1186/s12888-020-02967-5. BMC Psychiatry. 2020. PMID: 33228573 Free PMC article.
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R. Numata S, et al. Among authors: tsuboi t. Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11. Neuropsychopharmacol Rep. 2021. PMID: 33704931 Free PMC article.
865 results